GlassScriptPhysician profile
David J Schrieber
NPI 1548697162
$840.38
in general payments reported to CMS, 2019-2025
13 companies · $549 in 2025
The $549 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.65 · 2024: $273 · 2025: $549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $821.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $169.03 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Treace Medical Concepts, INC. | $165.26 | 2024-2025 | |
| Eclipse Technology Solutions INC. | $147.36 | 2024-2025 | |
| Amgen INC. | $78.63 | 2024-2025 | Krystexxa |
| Smith+Nephew, INC. | $67.50 | 2024-2025 | Stravix Mesh, Grafix Pl, Collagenase Santyl |
| Reprise Biomedical, INC. | $40.63 | 2025 | Miro 3d, Miro3d |
| Orthofix Medical, INC. | $40.40 | 2024-2025 | Physio-Stim |
| Next Science LLC | $33.19 | 2024 | Surgx, Xperience, Blastx |
| Ethicon US, LLC | $25.50 | 2025 | Megadyne |
| Lifenet Health | $20.94 | 2025 | Theragenesis Wound Matrix |
| Polarityte, INC. | $18.65 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $16.97 | 2024 | Dupixent |
| Electromed, INC. | $16.32 | 2024 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Schrieber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.